Xu, Dongping

Publishing since 1989 (Dinosaur)

Has published 344 publications in 22 years

Number of publications published per year by Xu, Dongping. (Source : PubMed)

Distribution of publications types for Xu, Dongping. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Xu D, Chen M, Guo Y, Liang G, Zhang B, Tan J, Magdalou J, Wang H. Synergistic antifibrotic effect of verapamil and interferon-gamma in rats: partially based on enhanced verapamil oral bioavailability.  Eur J Gastroenterol Hepatol  2010;22;4  
•  Wang J, Zhang Y, Xu D, Shao W, Lu Y. Evaluation of the Sysmex UF-1000i for the diagnosis of urinary tract infection.  Am. J. Clin. Pathol.  2010;133;4  
•  Xu D, Cao J, Qian S, Li L, Hu C, Weng Q, Lou J, Zhu D, Zhu H, Hu Y, He Q, Yang B. 5k, a novel beta-O-demethyl-epipodophyllotoxin analogue, inhibits the proliferation of cancer cells in vitro and in vivo via the induction of G2 arrest and apoptosis.  Invest New Drugs  2010  
•  Xu D, Sun B, Wan X, Ke Y. Reformation of medical education in China.  Lancet  2010  
•  Zhang YL, Wan YJ, Wang ZY, Xu D, Pang XS, Meng L, Wang LH, Zhong BS, Wang F. Production of dairy goat embryos, by nuclear transfer, transgenic for human acid beta-glucosidase.  Theriogenology  2010;73;5  
•  Xu D, Lin L, Lin X, Huang Z, Lei Z. Immunoregulation of autocrine prolactin: Suppressing the expression of costimulatory molecules and cytokines in T lymphocytes by prolactin receptor knockdown.  Cell. Immunol.  2010  
•  Zeng J, Ge Z, Wang L, Li Q, Wang N, Björkholm M, Jia J, Xu D. The histone demethylase RBP2 Is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells.  Gastroenterology  2010;138;3  
•  Xu D, Jiang HR, Li Y, Pushparaj PN, Kurowska-Stolarska M, Leung BP, Mu R, Tay HK, McKenzie AN, McInnes IB, Melendez AJ, Liew FY. IL-33 exacerbates autoantibody-induced arthritis.  J. Immunol.  2010;184;5  
•  Liu Y, Zhong Y, Zou Z, Xu Z, Li B, Ren X, Bai S, Wang L, Li X, Dai J, Wang Y, Mao P, Xu D. Features and clinical implications of hepatitis B virus genotypes and mutations in basal core promoter/precore region in 507 Chinese patients with acute and chronic hepatitis B.  J. Clin. Virol.  2010;47;3  
•  Yuan XL, Chen L, Li MX, Dong P, Xue J, Wang J, Zhang TT, Wang XA, Zhang FM, Ge HL, Shen LS, Xu D. Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner.  Clin. Immunol.  2010;134;3  

[ See timeline ] [ See all publications ]